Last updated on October 2019

Maximal Use Study of Tapinarof Cream 1% in Adults With Extensive Plaque Psoriasis

Brief description of study

This is an open-label, multicenter study to evaluate the systemic exposure and safety of topical tapinarof cream, 1% under conditions of maximal use in adults with plaque psoriasis.

Detailed Study Description

Clinical Study Identifier: NCT04042103

Find a site near you

Start Over

Dermavant Investigational Site

San Antonio, TX United States
  Connect »